return to corporate website
Menu
Return to
www.noxopharm.com
Home
About Us
About Noxopharm
Board of Directors
Management Team
Scientific Advisors
Corporate Governance
Company Constitution
Sustainability
Noxopharm History
Research and Clinical Programs
Research and Clinical Programs
About Pharmorage
Investor Centre
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
Media Centre
Overview
Newsletters
Coverage
Investor Videos
NOX Insights
Noxopharm Podcasts
Contact Us
Contact Us
Partnering
Working at Noxopharm
Newsletter Email Alerts
ASX Announcements Email Alerts
Investor Centre
Home
>
Investor Centre
>
ASX Announcements
Share Price
ASX Announcements
Why Invest in Noxopharm
Presentations & Interviews
Annual Reports
Financial Reports
Analyst Reports
Investor Fact Sheet
Investor FAQs
Upcoming Events
Privacy Policy
Share Registry Information
ASX Announcements
Filter by Year:
2022
2021
2020
2019
2018
2017
2016
8-Dec-2020
Noxopharm Corporate Presentation December Investor Webinar
7-Dec-2020
Pre-Clinical Breakthrough Discovery Set to Expand Pipeline
4-Dec-2020
Noxopharm December Investor Webinar Details
3-Dec-2020
Cleansing Statement
3-Dec-2020
Proposed issue of Securities - NOX
3-Dec-2020
Noxopharm Completes A$23m Placement to Fund Clinical Studies
1-Dec-2020
Appendix 2A
1-Dec-2020
Trading Halt
27-Nov-2020
Change of Director's Interest Notice - PM
27-Nov-2020
Lapsing of Unlisted Options
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
